Likewise, a study involving 111 patients with adenocarcinoma with EGFR mutation found that exon 19 deletion was independently associated with acquired T790M mutation (p = 0.003) in a multivariable analysis.21 This evidence concerns the gene EGFR and adenocarcinoma.